| Timing variables | AF at 7 days | AF at 3 months | AF at 6 months | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Yes (n = 16) | No (n = 101) | p | Yes (n = 16) | No (n = 100) | p | Yes (n = 20) | No (n = 96) | p | ||
| Age | 65.94 ± 10.45 | 64.62 ± 6.77 | > 0.05 | 67.50 ± 8.53 | 64.27 ± 7.04 | > 0.05 |
68.35 ± 7.10 |
63.96 ± 7.15 |
<0.05* | |
| BMI | 23.41 ± 3.23 | 22.94 ± 2.83 | >0.05 | 23.63 ± 3.21 | 22.90 ± 2.84 | > 0.05 |
23.49 ± 2.68 |
22.90 ± 2.93 |
>0.05 | |
| eGFR | 67.88 ± 22.40 | 63.30 ± 18.82 | > 0.05 | 64.19 ± 28.40 | 64.34 ± 17.11 | > 0.05 | 57.85 ± 16.53 |
65.67 ± 19.16 |
>0.05 | |
| Sex | Male | 13 (13.4) | 84 (86.6) | >0.05 | 13 (13.4) | 84 (86.6) | > 0.05 | 18 (18.6) | 79 (81.4) | > 0.05 |
| Female | 3 (15.0) | 17 (85.0) | 3 (15.8) | 16 (84.2) | 2 (10.5) | 17 (89.5) | ||||
| Diabetes | Yes | 3 (7.7) | 36 (92.3) | >0.05 | 4 (10.5) | 34 (89.5) | > 0.05 | 2 (5.3) | 36 (94.7) | <0.05* |
| No | 13 (16.7) | 65 (83.3) | 12 (15.4) | 66 (84.6) | 18 (23.1) | 60 (76.9) | ||||
| Smoking | Yes | 8 (14.8) | 46 (85.2) | >0.05 | 7 (13.0) | 47 (87) | > 0.05 | 7 (13.0) | 47 (87.0) | > 0.05 |
| No | 8 (12.7) | 55 (87.3) | 9 (14.5) | 53 (85.5) | 13 (21.0) | 49 (79.0) | ||||
| Hypertension | Yes | 14 (14) | 87 (86.1) | > 0.05 | 14 (14.0) | 86 (86) | >0.05 | 19 (19.0) | 81 (81.0) | >0.05 |
| No | 2 (12.5) | 14 (87.5) | 2 (12.5) | 14 (87.5) | 1 (6.2) | 15 (93.8) | ||||
| PAD | Yes | 3 (21.4) | 11 (78.6) | > 0.05 | 2 (14.3) | 12 (85.7) | >0.05 | 3 (21.4) | 11 (78.6) | >0.05 |
| No | 13 (12.6) | 90 (87.4) | 14 (13.7) | 88 (86.3) | 17 (16.7) | 85 (83.3) | ||||
| Previous MI | Yes | 0 (0.0) | 10 (100) | >0.05 | 1 (10.0) | 9 (90) | > 0.05 | 2 (20.0) | 8 (80.0) | > 0.05 |
| No | 16 (15.0) | 91 (85.0) | 15 (14.2) | 91 (85.8) | 18 (17.0) | 88 (83.0) | ||||
| NYHA (≥ 3) | Yes | 3 (42.9) | 4 (57.1) | <0.05* | 3 (42.9) | 4 (57.1) | >0.05 | 1 (14.3) | 6 (85.7) | >0.05 |
| No | 12 (11.0) | 97 (89.0) | 13 (11.9) | 96 (88.1) | 19 (17.4) | 90 (82.6) | ||||
| Chronic kidney failure ≥ stage 4 | Yes | 6 (10.7) | 50 (89.3) | > 0.05 | 9 (16.4) | 46 (83.6) | >0.05 | 12 (21.8) | 43 (78.2) | > 0.05 |
| No | 10 (16.4) | 51 (83.6) | 7 (11.5) | 54 (88.5) | 8 (13.1) | 53 (86.9) | ||||
| Euro score ≥3% | Yes | 2 (28.6) | 5 (71.4) | >0.05 | 4 (57.1) | 3 (42.9) | >0.05 | 3 (42.9) | 4 (57.1) | >0.05 |
| No | 14 (12.7) | 96 (87.3) | 12 (11.0) | 97 (89.0) | 17 (15.6) | 92 (84.4) | ||||
| Preoperative EF | 66.75 ± 8.31 | 63.38 ± 12.05 | >0.05 | 65.56 ± 10.56 | 63.6 ± 11.88 | > 0.05 |
65.2 ± 9.53 |
63.59 ± 12.11 | >0.05 | |
| CPB duration (min) |
93.15 ± 29.55 |
94.05 ± 26.25 | >0.05 | 95.25 ± 29.05 | 94.0 ± 26.15 | >0.05 | 94.25 ± 27.35 |
94.05 ± 26.5 |
>0.05 | |
| Aortic clamp time (min) |
72.05 ± 24.50 |
74.05 ± 23.45 | > 0.05 | 73.05 ± 25.50 | 74.05 ± 23.95 | >0.05 | 73.05 ± 24.10 | 74.05 ± 23.15 | >0.05 | |
Entries are means±SD or numbers of patients. p‐values are nominal. AF = atrial fibrillation, BMI = body mass index, GFR: Glomerular Filtration Rate, NYHA: New York Heart Association, PAD: Peripheral artery disease, MI: Myocardial infarction, CPB: Cardiopulmonary bypass. *: Statistically significant difference.